A handout file photo shows a technician preparing specimens from a master H1N1 virus sample, for the pre-production of a vaccine against pandemic influenza A (H1N1) virus at a laboratory of GlaxoSmithKline in Dresden June 16, 2009.
REUTERS/GlaxoSmithKline/Handout
Related posts:
